Article
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis.
Endocrine - 1 Apr 2014
Barbaro Daniele, Incensati Roberto Mario, Materazzi Gabriele, Boni Giuseppe, Grosso Mariano, Panicucci Erica, Lapi Paola, Pasquini Cristina, Miccoli Paolo
Abstract excerpt
The mutation BRAF V600E is thought to be a putative prognostic marker of the aggressiveness of several cancers among which is also papillary thyroid cancer. Our study aimed to evaluate whether this mutation is associated with advanced stages of disease or with a worse prognosis in a series of pat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.